Anthrax vaccine and antibiotics: a safety check
NCT ID NCT04067011
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked at whether giving the anthrax vaccine AV7909 along with common antibiotics (ciprofloxacin or doxycycline) changes how the body processes those antibiotics. 210 healthy adults received the vaccine and antibiotics on a set schedule. The goal was to see if the vaccine affects antibiotic levels in the blood and whether the vaccine still triggers a strong immune response.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AV7909 (anthrax vaccine with adjuvant), ciprofloxacin, doxycycline
What this could lead to
If successful, this study could confirm that the anthrax vaccine AV7909 can be safely given alongside these antibiotics without changing how well the antibiotics work.
What could go wrong
This is a small, early-phase study in healthy adults, not people with anthrax. Results may not apply to real-world infection scenarios, and the vaccine's immune response might still be affected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTHRAX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Avail Clinical Research, LLC
DeLand, Florida, 32720, United States
-
Meridian Clinical Research, LLC
Omaha, Nebraska, 68134, United States
-
New Orleans Center for Clinical Research / Volunteer Research Group
Knoxville, Tennessee, 37920, United States
-
The Center for Pharmaceutical Research
Kansas City, Missouri, 64114, United States